Novavax (NVAX) Tops Q2 EPS by 12c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 10.65 +0.97 (10.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.68 | 52 Week High | $9.23 | |||
| Open | $10.01 | 52 Week Low | $1.16 | |||
| Day High | $10.67 | P/E | N/A | |||
| Day Low | $9.84 | EPS | $-0.30 | |||
| Volume | 6,009,467 | |||||
